Find and Pitch Jounalists, Get Your Story Covered

Tags: Celltrion subcutaneous infliximab inflammatory bowel disease infliximab infection

	Profile	Recent Articles on Subject
1	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	Studies Point to Several Options for Ulcerative Colitis After Anti-TNF Failure - about 2 months ago Alpha-Gal May Drive Sensitivity to IV Stelara in People With Red-Meat Allergies - 4 months ago Mirikizumab Effective in Crohn's Disease After Initial Standard Therapy Failure - 4 months ago Risankizumab Beats Ustekinumab for Previously Treated Crohn's - about 1 year ago
2	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Axatilimab-csfr 9 mg and 22 mg Vial Sizes for cGVHD - 3 months ago Ustekinumab-stba Receives FDA Approval for Autoimmune Disorder and Inflammatory Bowel Disease - 4 months ago New Study Assesses Ifinatamab Deruxtecan for Treatment of Small Cell Lung Cancer - 8 months ago J&J Submits sBLA To FDA for Guselkumab in Ulcerative Colitis - about 1 year ago
3	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	Subcutaneous options offer convenience for patients — and a valuable window for drugmakers - 3 months ago Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals - 5 months ago
4	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Bristol Myers Squibb Wins FDA Nod for Injectable Version of Blockbuster Cancer Drug - 3 months ago Merck Gets a Shot of Confidence From Pivotal Test of SubQ Injectable Keytruda - 5 months ago Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs - 7 months ago
5	Kristen Monaco MedPage Today	Imcivree Label Expanded; Weight Loss With Weekly Injection; Kidney Donation Chain - 4 months ago Complement Inhibitor Shows Promise for Rare Kidney Disorder - 6 months ago Investigational Once-Monthly Injectable Boosts Response Rate in Acromegaly - 9 months ago
6	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma - 4 months ago Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 7 months ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 7 months ago New First-Line Option for Pancreatic Cancer Approved - about 1 year ago Axatilimab Shows Efficacy in Recurrent/Refractory GVHD - over 1 year ago Neoadjuvant Cemiplimab Shows Potential as an Option for Cutaneous SCC - over 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - over 1 year ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Clinical Safety Data Show Switching Between Rituximab Biosimilars Does Not Increase Adverse Events - 5 months ago Non-Medical Switch to Infliximab Biosimilar Demonstrates Similar Outcomes for IBD - 7 months ago FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 7 months ago FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 10 months ago FDA Accepts sBLA for Bimekizumab-bkzx in Hidradenitis Suppurativa Treatment - about 1 year ago FDA Approves Tocilizumab-aazg as Biosimilar to Actemra for Multiple Indications - about 1 year ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - about 1 year ago FDA Approves Adalimumab-ryvk as Interchangeable Biosimilar for Humira - about 1 year ago Biosimilar Adalimumab, Etanercept Have Equivalent Effectiveness to Reference Drugs Over 48 Months - about 1 year ago Celltrion Seeks Approval From FDA for CT-P47 as Biosimilar of Tocilizumab - about 1 year ago Study: Biosimilarities Found Between Yusimry and Humira for Immune, Rheumatic Conditions - over 1 year ago FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira - over 1 year ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - over 1 year ago Subcutaneous Lecanemab Demonstrates Greater Amyloid Plaque Removal Than Intravenous Lecanemab - over 1 year ago
8	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Novel Anti-IgG Drug Hits Mark in Sjogren's Patients - 5 months ago Medicare Lags, Medicaid Leads for Biosimilar Uptake - 8 months ago Study Confirms: No Great Options for Treating VEXAS - 11 months ago Novel Drug OK'd for Ulcerative Colitis - over 1 year ago
9	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Inebilizumab for Myasthenia Gravis Reduces Steroid Burden - 5 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - over 1 year ago New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks - over 1 year ago New Data on CD40 Ligand Inhibitor for Relapsing MS - over 1 year ago
10	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	SC vs IV Administration Methods - 5 months ago

Journalists covering subcutaneous infliximab